Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 7/2022

Content (10 Articles)

PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer

Ronan Flippot, Anna Patrikidou, Mihaela Aldea, Emeline Colomba, Pernelle Lavaud, Laurence Albigès, Natacha Naoun, Pierre Blanchard, Mario Terlizzi, Camilo Garcia, Alice Bernard-Tessier, Alina Fuerea, Mario Di Palma, Bernard Escudier, Yohann Loriot, Giulia Baciarello, Karim Fizazi

Lupus Nephritis: Improving Treatment Options

Myrto Kostopoulou, Sofia Pitsigavdaki, George Bertsias

New Drug Delivery Systems Developed for Brain Targeting

  • Review Article

Shruti U. Rawal, Bhoomika M. Patel, Mayur M. Patel

Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews

Salmaan Kanji, Sydney Morin, Kyla Agtarap, Debanjali Purkayastha, Pierre Thabet, Dominick Bosse, Xiang Wang, Carole Lunny, Brian Hutton

Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC

  • NSCLC
  • Adis Drug Evaluation

Yahiya Y. Syed

Sutimlimab: First Approval

  • AdisInsight Report

Sohita Dhillon

Faricimab: First Approval

  • Edema
  • AdisInsight Report

Matt Shirley

Pacritinib: First Approval

Yvette N. Lamb

Correction to: Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals

  • Correction

Fabrizio Schifano, Valeria Catalani, Safia Sharif, Flavia Napoletano, John Martin Corkery, Davide Arillotta, Suzanne Fergus, Alessandro Vento, Amira Guirguis

Correction to: Daridorexant: First Approval

  • Open Access
  • Correction

Anthony Markham

Apr 22
Issue: 5/2022
Jun 22
Issue: 8/2022

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images